229 Suppression of TGF-beta2 in pancreatic cancer by the antisense oligonucleotide ap 12009: preclinical efficacy data as basis for clinical studies

✍ Scribed by G. Stauder; P. Jachimczak; R. Schlingensiepen; M. Goldbrunner; K. Graf; M. Kielmanowicz; M. Hafner; M. Szyrach; A. Bischof

• Book ID: 118620404
• Publisher: Elsevier Science
• Year: 2003
• Tongue: English
• Weight: 164 KB
• Volume: 1
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/s1359-6349(03)90262-x